Skip to main content
SpringerLink
Log in

Effect of mindfulness-based stress reduction on acute central serous chorioretinopathy: a randomized control trial

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To assess the positive effects of mindfulness-based stress reduction (MBSR) on the structural and functional outcomes of patients with central serous chorioretinopathy (CSCR).

Methods

This study included 60 patients with CSCR who were randomly allocated to one of two groups: MBSR or control (which did not practice MBSR). These groups were then evaluated in terms of best corrected visual acuity (BCVA) and central macular thickness (CMT) at months 1, 3, and 6.

Results

There were no significant differences in BCVA or mean CMT between the groups at the beginning of the study (p = 0.615 and p = 0.561, respectively). There were statistically significant differences between the groups in terms of BCVA at 1, 3, and 6 months (p = 0.018, p = 0.001, and p = 0.002, respectively). There were also significant differences in the mean CMT across the groups at the first, third, and sixth months (p < 0.001, p = 0.001, and p < 0.001, respectively).

Conclusion

MBSR may have beneficial outcomes in the early treatment of patients with CSCR, resulting in faster resolution of subretinal fluid and enhancement of BCVA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data and material availability

Available upon a reasonable request.

Code availability

Not applicable.

References

  1. Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N et al (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82–118

    Article  CAS  PubMed  Google Scholar 

  2. Daruich A, Matet A, Marchionno L, De Azevedo J-D, Ambresin A, Mantel I et al (2017) Acute central serous chorioretinopathy: factors influencing episode duration. Retina 37:1905–1915

    Article  PubMed  PubMed Central  Google Scholar 

  3. van Rijssen TJ, van Dijk EHC, Yzer S, Ohno-Matsui K, Keunen JEE, Schlingemann RO et al (2019) Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res 73:100770

    Article  PubMed  Google Scholar 

  4. Erikitola OC, Crosby-Nwaobi R, Lotery AJ, Sivaprasad S (2014) Photodynamic therapy for central serous chorioretinopathy. Eye (Lond) 28:944–957

    Article  CAS  PubMed  Google Scholar 

  5. Yadav NK, Jayadev C, Mohan A, Vijayan P, Battu R, Dabir S et al (2015) Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: Safety profile and treatment outcome. Eye 29:258–265

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Pitcher JD 3rd, Witkin AJ, DeCroos FC, Ho AC (2015) A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study. Br J Ophthalmol 99:848–852

    Article  PubMed  Google Scholar 

  7. Lotery A, Sivaprasad S, O’Connell A, Harris RA, Culliford L, Ellis L et al (2020) Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double blind, placebo-controlled trial. Lancet 395:294–303

    Article  CAS  PubMed  Google Scholar 

  8. Chhablani J, Rani PK, Mathai A, Jalali S, Kozak I (2014) Navigated focal laser photocoagulation for central serous chorioretinopathy. Clin Ophthalmol 8:1543–1547

    Article  PubMed  PubMed Central  Google Scholar 

  9. Singh SR, Goté JT, Chhablani J (2023) Randomized controlled trials in central serous chorioretinopathy: a review. Eye (Lond). https://doi.org/10.1038/s41433-023-02509-9

    Article  PubMed  Google Scholar 

  10. Conrad R, Geiser F, Kleiman A, Zur B, Karpawitz-Godt A (2014) Temperament and character personality profile and illness-related stress in central serous chorioretinopathy. Sci World J 2014:631687

    Article  Google Scholar 

  11. Nongrem G, Surve A, Venkatesh P, Sagar R, Yadav RK, Chawla R, Vohra R, Kumar A (2021Dec) Effect of short-term meditation training in central serous chorioretinopathy. Indian J Ophthalmol 69(12):3559–3563

    Article  PubMed  PubMed Central  Google Scholar 

  12. Yoshioka H, Katsume Y, Akune H (1982) Experimental central serous chorioretinopathy in monkey eyes: Fluorescein angiographic findings. Ophthalmologica 185:168–178

    Article  CAS  PubMed  Google Scholar 

  13. Kutz I, Borysenko JZ, Benson H (1985) Meditation and psychotherapy: a rationale for the integration of dynamic psychotherapy, the relaxation response, and mindfulness meditation. Am J Psychiatr. 142(1):1e8

    Google Scholar 

  14. Gagrani M, Faiq MA, Sidhu T, Dada R, Yadav RK, Sihota R et al (2018) Meditation enhances brain oxygenation, upregulates BDNF and improves quality of life in patients with primary open angle glaucoma: A randomized controlled trial. Restor Neurol Neurosci 36:741–753

    CAS  PubMed  Google Scholar 

  15. Dada T, Mittal D, Mohanty K, Faiq MA, Bhat MA, Yadav RK et al (2018) Mindfulness meditation reduces intraocular pressure, lowers stress biomarkers and modulates gene expression in glaucoma: a randomized controlled trial. J Glaucoma 27:1061–1067

    Article  PubMed  Google Scholar 

  16. Dudani AI, Hussain N, Ramakrishnan M, Telang O, Patil VM, Dudani K, Jadhav B, Gholap V (2021) Psychiatric evaluation in patients with central serous chorioretinopathy in Asian Indians. Indian J Ophthalmol 69(5):1204–1207

    Article  PubMed  PubMed Central  Google Scholar 

  17. Tekin K, Sekeroglu MA, Cankaya AB, Teke MY, Doguizi S, Yilmazbas P (2018) Intravitreal bevacizumab and ranibizumab in the treatment of acute central serous chorioretihopathy: a single center retrospective study. Semin Ophthalmol 33(2):265–270

    PubMed  Google Scholar 

  18. Azam MA, Katz J, Fashler SR, Changoor T, Azargive S, Ritvo P (2015) Heart rate variability is enhanced in controls but not maladaptive perfectionists during briefmindfulness meditation following stress-induction: a stratified-randomized trial. Int J Psychophysiol Off J Int Organ Psychophysiol 98(1):27–34

    Google Scholar 

  19. Dada T, Ramesh P, Shakrawal J (2020) Meditation: a polypill for comprehensive management of glaucoma patients. J Glaucoma 29(2):133–140

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

This research received no specific grants from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Seyrantepe Hamidiye Training and Research Hospital, University of Health Sciences, Cumhuriyet Street, Huzur District, 34396, Seyrantepe, Istanbul, Turkey

    Delil Özcan

  2. Department of Ophthalmology, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey

    Murat Karapapak

Authors
  1. Delil Özcan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Murat Karapapak
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conception: DÖ, MK. Design of the work: DÖ, MK. Analysis: DÖ, MK. Interpretation of data: DÖ, MK. Writing and Review: DÖ, MK. Approved submitted version: DÖ, MK.

Corresponding author

Correspondence to Delil Özcan.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Ethical approval

This cross-sectional study adhered to the tenets of the Declaration of Helsinki and was approved by the ethics committee of a tertiary training and research hospital.

Consent to participate

All participants provided written informed consent to participate in the study.

Consent for publication

Study participants provided written informed consent for publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Özcan, D., Karapapak, M. Effect of mindfulness-based stress reduction on acute central serous chorioretinopathy: a randomized control trial. Int Ophthalmol 44, 183 (2024). https://doi.org/10.1007/s10792-024-03102-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10792-024-03102-z

Keywords

Search

Navigation